这对罗氏也许是有利的，其创始人家族通过双重股权结构的设计，从而牢牢地控制着公司，但却使其他投资者感到沮丧。
That may be fine with Roche’s patient founding family, which controls the firm thanks to its dual-share structure, but it could dismay other investors.
这对罗氏也许是有利的，其创始人家族通过双重股权结构的设计，从而牢牢地控制着公司，但却使其他投资者感到沮丧。
That may be fine with Roche’s patient founding family, which controls the firm thanks to its dual-share structure, but it could dismay other investors.
应用推荐